Cancer immunotherapy: are the results discouraging? Can they be improved?

Adv Cancer Res. 1992;59:245-322. doi: 10.1016/s0065-230x(08)60308-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Cytokines / therapeutic use
  • Histocompatibility Antigens / analysis
  • Humans
  • Immunotherapy*
  • Immunotherapy, Adoptive
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • T-Lymphocytes / immunology

Substances

  • Cytokines
  • Histocompatibility Antigens